Med8 is a subunit of the mediator complex, a critical multiprotein assembly that acts as a transcriptional coactivator in eukaryotic cells. It functions by conveying regulatory signals from transcription factors to the RNA polymerase II (Pol II) enzyme, which is responsible for synthesizing messenger RNA (mRNA) from DNA templates. The mediator complex, including Med8, is thereby integral to the regulation of gene expression.
The function of Med8 within the mediator complex is to participate in the transduction of signals from specific gene regulatory elements to the general transcription machinery. It is involved in the critical processes of transcription initiation and elongation. By examining the effects of Med8 activators, researchers could gain valuable insights into the regulation of transcription and the role of the mediator complex in various cellular processes, such as development, cell differentiation, and response to environmental cues. Understanding the mechanism of action of Med8 activators would be instrumental in dissecting the complex pathways of gene regulation and could illuminate new aspects of chromatin organization and the dynamics of the transcription machinery.
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 beta (GSK3β). This inhibition can alter the activity of various transcription factors, and Med8, being part of the Mediator complex involved in transcription, can be indirectly activated as a result. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterase (PDE), leading to increased cAMP levels. This can activate PKA which phosphorylates several transcription factors, indirectly activating Med8 through its role in the Mediator complex. | ||||||